1,721,196 research outputs found
L'HB-HTA: esperienze, buone pratiche e strumenti del progetto europeo AdHopHTA
No full textIl capitolo discute e presenta alcune evidenze sviluppate nell'ambito del Progetto Europeo AdHopHTA. Il Progetto si pone l'obiettivo di maturare metodi, strumenti e buone pratiche per l'implementazione dell'Hospital-Based Health Technology Assessment nelle organizzazioni sanitari
L'approccio metodologico
No full textIl contributo illustra l'approccio metodologico seguito nell'ambito del progetto di ricerca oggetto del volum
Il caso del Policlinico A. Gemelli
No full textIl contributo presenta i principali findings del progetto di ricerca relativi al caso del Policlinico A. Gemelli
Introduzione all'Health Technology Assessment: Principi, Organizzazione e Metodi per il Governo dell'Innovazione
No full textLa monografia è dedicata alla presentazione dei principi dei metodi e degli strumenti dell'health technology assessment, approccio utilizzato per valutare le implicazioni dell'introduzione delle tecnologie sanitarie all'interno delle organizzazioni sanitarie
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future
No full textTo appraise the methodological quality of the Italian pharmaco -
economic models.
Background: In most of the developed countries the institution of HTA
agencies has been one of the major concerns in order to support the decisions
for reimbursement of new drugs. Italy is experiencing a remarkable lack in
this field.
Design: 18 Italian models published between 1998 and 2005 selected using
EMBASE and MEDLINE search engines. Inclusion criteria: (a) Italian
nationality of the first author, (b) Italian baseline population. Studies were
appraised using the checklist developed by Philips et al. (2004).
Results: Although the alternatives and the basic framework of the
pharmacoeconomic models are usually well defined and specified, the studies
present a lack of data about treatment effects, utilities, analysis of uncertainty,
considerations about heterogeneity and generalisability of results.
Conclusion: Despite the high level of competence of the authors, the
pharmacoeconomic models quality is largely affected by the scarce interest
of Italian institutions for the use of ICER-based criteria, in favour of a priceminimization
one. The institutional use of ICER-based criteria should be
strongly recommended for a rational resource use in healthcare
Ruolo e Regole degli stakeholder nel processo di HTA. Le Evidenze emerse dall’Health Policy Forum della SIHTA
No full textL'articolo discute il ruolo degli stakeholder nel processo di HT
Integrating environmental sustainability into health technology assessment: an international survey of HTA stakeholders
Full text linkHealth technologies play a relevant role in environmental sustainability (ES).
However, limited evidence exists on approaches and methods to integrate ES into the Health
Technology Assessment (HTA). The purpose of this study is: (i) to provide an overview of global HTA organizations’ progression toward the integration of ES into HTA; (ii) to investigate various paths for this integration, highlighting obstacles, priorities, potential approaches, and methods. Data were collected via questionnaires from organizations belonging to HTA networks, International Network of Agencies for Health Technology Assessment, and European Network for HTA. To complement the results of the survey, the authors carried out a desk analysis with strategic documents available on institutional websites. The survey included twenty-six respondents from twenty different countries (thirtythree percent response rate). Among the study’s participants, there is a notable acknowledgment of the importance of integrating ES into HTA. However, only nine organizations are actively engaged in these integration efforts, each employing unique methodologies and perspectives. There is a substantial consensus on the application of life cycle assessment, with a particular emphasis on the use of environmentally extended input–output analysis, and a stronger preference for cost-utility analysis. Nevertheless, evidence on integrating ES into HTA remains scarce. Major challenges identified include data collection difficulties and the necessity for interdisciplinary teams. Our study represents a preliminary effort to systematize initiatives aimed at integrating ES into HTA. Further research is required to customize methods and tools for appropriately evaluating the environmental impacts of technologies. The findings suggest that achieving ES-HTA integration demands a multi-tiered, interdisciplinary approach
RICERCA SCIENTIFICA E TRASFERIMENTO TECNOLOGICO Generazione, valorizzazione e sfruttamento della conoscenza nel settore biomedico
No full textIl libro affronta i modelli organizzativi per il trasferimento tecnologico in campo biomedic
- …
